Navigation Links
A Look Inside, Factors of Health - Research Report on Novogen Limited, Sanofi SA, ISIS Pharmaceuticals, Inc., Amgen, Inc. and Gilead Sciences, Inc.
Date:2/21/2013

t

Sanofi's shares rallied after the U.S. Food and Drug Administration (FDA) accepted lixisenatide for review. Lixisenatide is the first once-daily treatment of adults with type 2 diabetes mellitus. Lixisenatide has also been approved for the European Union, and will be launched as Lyxumia later in the first quarter. This follows regulatory approvals for Kynamro, Zaltrap, and Aubagio. Additionally, Sanofi's subsidiary Genzyme also announced positive new data from phase 3 ENGAGE and ENCORE studies of eliglustat tartrate, an investigational oral therapy for Gaucher disease type 1. With a string of approvals to boast of, many believe that the pharmaceutical giant will be able to generate strong revenue in the upcoming quarters.  Warren Buffett is among Sanofi's shareholders, along with Abrams Capital. The Full Research Report on Sanofi SA - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.NationalTradersAssociation.org/r/full_research_report/63b2_SNY]

--

ISIS Pharmaceuticals, Inc. Research Report

ISIS and Genzyme have announced the US Food and Drug Administration (FDA) approval of their new product, the KYNAMROTM injection.  The injection reduces low density liproprotein-cholesterol, apoliprotein B, total cholesterol, and high density lipoprotein-cholesterol in patients with homozygous familial hypercholesterolemia (HoFH). HoFH is a rare inherited condition which makes the body unable to remove LDL cholesterol. In the United States, HoFH occurs in one in a million individuals, and for patients with this condition, heart attacks, and death can occur before age 30. Analysts expect that the product will earn $400 million in peak sales, with Isis getting 30 percent to 50 percent of the profit, depending on total sales. Sanofi, the pharma gia
'/>"/>

SOURCE National Traders Association
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Ariosa Diagnostics Announces Publication of Study on Influential Factors Affecting Fetal DNA Concentration in Blood of Pregnant Women
2. PROLOR Biotech Announces Presentation of Data on Its Long-Acting Clotting Factors at World Federation of Hemophilia World Congress
3. Pro Bono Bio Announces the Successful Development of Subcutaneous and Long-Acting Blood Factors VIIa,VIII and IX for the Treatment of Haemophilia
4. Sequenom Announces Participation at the Lazard Capital Markets 8th Annual Healthcare Conference
5. Bayer HealthCares Cotavance® Drug Eluting Balloon With Paccocath® Technology Reduced Five-Year Target Lesion Revascularization Rates by 59 Percent in PAD Patients Compared to Those Treated With Uncoated Balloon
6. Organovo to Present at Lazard Capital Markets 8th Annual Healthcare Conference
7. Pharmasset to Present at the Lazard Capital Markets Healthcare Conference
8. inVentiv Health Selected to Provide Sales Operations Support for Santarus
9. Masimo to Present at 23rd Annual Piper Jaffray Health Care Conference
10. Hong Kong Department of Health to Combat Sudden Cardiac Arrest With Powerheart AEDs
11. Nations Best Health Care Organizations for Patient Satisfaction, Core Measures Honored by Press Ganey
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... 2014 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") ... orders to $5.8 million and provides a good start to Q4.  ... North America and one in the Middle ... at record levels," said Peter Bruijns , President & CEO. ... of Q3 than they have been for any complete year since ...
(Date:10/20/2014)...  GenVec, Inc. (NASDAQ: GNVC ) today announced ... its board of directors effective on October 24, 2014.   Dr. ... as its chairman from June 2006 to November 2013.  During ... Governance and Audit Committees of the board.  ... dedicated service to GenVec, and its stockholders," said Wayne ...
(Date:10/20/2014)... OncLive® is pleased to ... Thomas Jefferson University has joined its Strategic Alliance ... Partnership program, the Sidney Kimmel Cancer Center at ... of the Center’s cutting-edge research programs, comprehensive approach ... other health care professionals from the Sidney Kimmel ...
(Date:10/20/2014)... Local veterinary surgeon, Dr. Tim McCarthy is ... donor stem cells for dogs with osteoarthritis. Dr. McCarthy ... performed clinical stem cell therapy for 7 years. The ... a single injection of donor stem cells into one ... and inflammation in the treated joints. , Candidates ...
Breaking Biology Technology:Zola P. Horovitz To Retire From GenVec Board 2Sidney Kimmel Cancer Center at Thomas Jefferson University Partners With OncLive 2Sidney Kimmel Cancer Center at Thomas Jefferson University Partners With OncLive 3Cascade Veterinary Referral Center Seeks Candidates for an Investigational Study of Stem Cells for Dogs with Arthritis 2
... familiar with these three words, after all that has happened ... shown the importance of being current with ones network security ... attacks came via the blaster worm, which took advantage of ... Following closely on its heels were Sobig, Nacha, and ...
... bread and butter of Wisconsins economic growth will be ... to transfer our best technology to the marketplace, controlling ... ensuring theres a 21st century infrastructure in place to ... to the equation, too, that may prove as vital ...
... WI- Frost & Sullivan has announced that Camtronics ... Corporation as the recipient of both the 2003 ... information management market and the 2003 Market Penetration Leadership ... , ,Outstanding achievements in these areas have helped ...
Cached Biology Technology:Athletics, pop culture and the arts 2Athletics, pop culture and the arts 3Camtronics Receives Health IT Awards 2
(Date:10/15/2014)... in female mice to an enzyme activated by the ... resistant to respiratory infections than males. Now, an international ... bacterial pneumonia in female mice is linked to the ... that this enzyme is ultimately activated by the release ... lead by Professor Lester Kobzik at the Harvard University ...
(Date:10/14/2014)... Like discriminating thieves, prostate cancer tumors scavenge and hoard ... But such avarice may be a fatal weakness. ... to kill prostate cancer cells by delivering a trove ... the diseased cells brimming with the mineral, leaving non-cancer ... drugs already commercially available for other uses, could soon ...
(Date:10/14/2014)... of the planet,s leading questions is how to produce ... variable climate. The Food and Agriculture Organization of the ... over the next 40 years to feed a growing ... the necessary rise in food production. Plants—grains, cereals, ... supporting livestock. Current research must tap into our ...
Breaking Biology News(10 mins):Prostate cancer's penchant for copper may be a fatal flaw 2Building a bridge from basic botany to applied agriculture 2Building a bridge from basic botany to applied agriculture 3
... KAN. -- A Kansas State University professor is ... by creating a map of learning. Candice ... four years looking at students and self-efficacy. Self-efficacy ... often linked with academic motivation, learning and achievement. ...
... University of Georgia researchers are working to understand ... is struggling in northern California,s Sacramento-San Joaquin Bay Delta, ... and pollution. Doug Peterson and Robert Bringolf, both ... Resources, have begun work on the one-year, $200,000 joint ...
... deep within the human gut they leave no corner of ... life on earth that no other organism can lay claim ... around us. Microbes may be the smallest of living creatures, ... In a new two volume set, the Handbook of Molecular ...
Cached Biology News:Finding their way: Study shows connection between academic direction and student learning 2Finding their way: Study shows connection between academic direction and student learning 3UGA researchers study threats to white sturgeon 2UGA researchers study threats to white sturgeon 3Handbook of Molecular Microbial Ecology: Exploring the World of the Microbes 2
... for interferons are cytopathic effect inhibition assays, ... The neutralization assay measures the antibody's ... the cytokine. Sample types include; tissue culture ... these assays, one unit is defined as ...
Rabbit polyclonal to Shigella Immunogen: Mixture of S. boydii, S. flexneri & S. dysenteriae....
... The GSTTag Monoclonal Antibody is ... high affinity to the 26 kDa ... . This purified antibody is suitable ... GSTTag sequence expressed in E. coli ...
... slides for microRNA expression profiling ... unique Locked Nucleic Acid (LNA) technology to ... for short microRNA (miRNA) targets. miRCURY LNA ... total RNA (no need for microRNA enrichment) ...
Biology Products: